Viewing Study NCT02912533


Ignite Creation Date: 2025-12-25 @ 3:03 AM
Ignite Modification Date: 2026-03-01 @ 12:03 PM
Study NCT ID: NCT02912533
Status: COMPLETED
Last Update Posted: 2019-04-02
First Post: 2016-09-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Long-term Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)
Sponsor: Kissei Pharmaceutical Co., Ltd.
Organization:

Study Overview

Official Title: None
Status: COMPLETED
Status Verified Date: 2019-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to investigate the safety and efficacy for 52-week dosing of JR-131 in renal anemia patients with chronic kidney disease (CKD).
Detailed Description: None

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: